{"id":473,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","title":{"rendered":"Limites des preuves LL-37\u00a0: Peptide endog\u00e8ne, livraison technique et mat\u00e9riel de catalogue"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">\u00ab\u00a0LL-37\u00a0\u00bb peut faire r\u00e9f\u00e9rence \u00e0 un peptide de d\u00e9fense humaine endog\u00e8ne, \u00e0 un r\u00e9actif de test synth\u00e9tique ou \u00e0 un syst\u00e8me d'administration biologique modifi\u00e9. Les r\u00e9sultats d\u2019une de ces interventions ne peuvent pas \u00eatre transf\u00e9r\u00e9s automatiquement \u00e0 une autre.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Ce que montre le dossier<\/h2><ul class=\"wp-block-list\"><li>L'expression endog\u00e8ne ne constitue pas une preuve d'une administration exog\u00e8ne.<\/li><li>Un organisme modifi\u00e9 exprimant LL-37 n\u2019est pas \u00e9quivalent \u00e0 un LL-37 synth\u00e9tique isol\u00e9.<\/li><li>FDA rapporte des informations insuffisantes sur la s\u00e9curit\u00e9 humaine et signale des probl\u00e8mes d'immunog\u00e9nicit\u00e9, de reproduction et de tumeurs sp\u00e9cifiques aux tissus.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png\" alt=\"Scientifique examinant les analyses bact\u00e9riennes et les donn\u00e9es de recherche sur les membranes peptidiques\" class=\"wp-image-461\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Illustration \u00e9ditoriale originale utilis\u00e9e pour identifier le th\u00e8me de recherche. Il ne d\u00e9crit pas un lot catalogue, un m\u00e9dicament approuv\u00e9, un r\u00e9sultat de test ou une utilisation clinique.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">La fronti\u00e8re entre l\u2019identit\u00e9 et la preuve<\/h2><p class=\"wp-block-paragraph\">Un article sur un micro-organisme exprimant LL-37 teste l\u2019intervention technique compl\u00e8te, y compris son syst\u00e8me d\u2019administration. Cela ne doit pas \u00eatre cit\u00e9 comme si les participants recevaient un flacon de LL-37 isol\u00e9.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Contexte endog\u00e8ne<\/strong><span>Cath\u00e9licidine humaine dans l'immunit\u00e9 inn\u00e9e<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexte du test<\/strong><span>Peptide synth\u00e9tique dans des conditions in vitro sp\u00e9cifi\u00e9es<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexte de s\u00e9curit\u00e9<\/strong><span>FDA identifie les principales lacunes en mati\u00e8re d'information et les pr\u00e9occupations non cliniques<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Ce qui appartient au dossier mat\u00e9riel<\/h2><p class=\"wp-block-paragraph\">Pour la caract\u00e9risation des mat\u00e9riaux, la confirmation de la s\u00e9quence, la puret\u00e9, la masse, l'agr\u00e9gation et les contr\u00f4les des endotoxines ou de la charge biologique, r\u00e9pondez \u00e0 diff\u00e9rentes questions. Aucun ne fournit de conclusion sur l\u2019efficacit\u00e9 humaine.<\/p><h2 class=\"wp-block-heading\">R\u00e8gle \u00e9ditoriale<\/h2><p class=\"wp-block-paragraph\">Utilisez le nom exact de l\u2019intervention, le mod\u00e8le, la population et le point final de l\u2019enregistrement cit\u00e9. Ne convertissez pas une association, un m\u00e9canisme, un r\u00e9sultat animal, un dossier de m\u00e9dicament fini approuv\u00e9 ou un test analytique en une all\u00e9gation concernant un lot du catalogue sans rapport.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00ab\u00a0LL-37\u00a0\u00bb peut faire r\u00e9f\u00e9rence \u00e0 un peptide de d\u00e9fense humaine endog\u00e8ne, \u00e0 un r\u00e9actif de test synth\u00e9tique ou \u00e0 un syst\u00e8me d'administration biologique modifi\u00e9. Les r\u00e9sultats d\u2019une de ces interventions ne peuvent pas \u00eatre transf\u00e9r\u00e9s automatiquement \u00e0 une autre.<\/p>","protected":false},"author":1,"featured_media":638,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"348","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"In-vitro evidence and current FDA safety assessment","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"LL-37 ocular expression and antimicrobial activity\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16020269\/\",\"note\":\"Human tissue expression and in-vitro assays; PMID 16020269.\"},{\"title\":\"LL-37 analog activity, cytotoxicity and serum inhibition\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15980359\/\",\"note\":\"In-vitro context; PMID 15980359.\"},{\"title\":\"FDA list of bulk substances with significant safety concerns\",\"url\":\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\",\"note\":\"Current FDA LL-37 safety summary.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-473","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>LL-37 Evidence Boundaries: Endogenous vs Engineered<\/title>\n<meta name=\"description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\" \/>\n<meta property=\"og:description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"name\":\"LL-37 Evidence Boundaries: Endogenous vs Engineered\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Limites des preuves LL-37\u00a0: endog\u00e8nes ou artificielles","description":"\u00ab\u00a0LL-37\u00a0\u00bb peut faire r\u00e9f\u00e9rence \u00e0 un peptide de d\u00e9fense humaine endog\u00e8ne, \u00e0 un r\u00e9actif de test synth\u00e9tique ou \u00e0 un syst\u00e8me d'administration biologique modifi\u00e9. R\u00e9sultats de l\u2019un d\u2019entre eux\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_locale":"fr_FR","og_type":"article","og_title":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","og_description":"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026","og_url":"https:\/\/nhdbio.com\/fr\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","url":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","name":"Limites des preuves LL-37\u00a0: endog\u00e8nes ou artificielles","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"\u00ab\u00a0LL-37\u00a0\u00bb peut faire r\u00e9f\u00e9rence \u00e0 un peptide de d\u00e9fense humaine endog\u00e8ne, \u00e0 un r\u00e9actif de test synth\u00e9tique ou \u00e0 un syst\u00e8me d'administration biologique modifi\u00e9. R\u00e9sultats de l\u2019un d\u2019entre eux\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=473"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/473\/revisions"}],"predecessor-version":[{"id":503,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/473\/revisions\/503"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/638"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}